HATTA Yoshihiro | Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine
スポンサーリンク
概要
- 同名の論文著者
- Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicineの論文著者
関連著者
-
Takeuchi Jin
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Sawada Umihiko
Division Of Hematology And Oncology Kasukabe Municipal Hospital
-
HATTA Yoshihiro
Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine
-
MIURA Katsuhiro
Department of Hematology and Rheumatology, Division of Medicine, Nihon University School of Medicine
-
Kura Yoshimasa
Division Of Hematology And Oncology Kasukabe Municipal Hospital
-
Miura Katsuhiro
Division Of Medicine Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Kondo Takeshi
北海道大学 医学研究科消化器内科学
-
Takeuchi Jin
Division Of Medicine I Department Of Internal Medicine Nihon University School Of Medicine
-
Takeuchi Jin
First Department Of Internal Medicine Nihon University School Of Medicine
-
Hatta Yoshihiro
First Department Of Internal Medicine Nihon University School Of Medicine
-
Tanaka Junji
Japan Society For Hematopoietic Cell Transplantation Adult Data Management Committee
-
Hatta Yoshihiro
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Hatta Yoshihiro
Division Of Medicine Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Tanaka Shinya
Department Of Pathology Laboratory Of Cancer Research Hokkaido University Graduate School Of Medicine
-
Kobayashi Sumiko
Department Of Hematology And Rheumatology Division Of Medicine Nihon University School Of Medicine
-
MIURA Katsuhiro
Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine
-
YAMAZAKI Tetsuo
Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine
-
ISHIZUKA Hikaru
Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine
-
TAKEI Kazuhiro
Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine
-
KURA Yoshimasa
Division of Hematology and Oncology, Kasukabe Municipal Hospital
-
TAKEUCHI Jin
Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine
-
ISHIZUKA Hikari
Department of Hematology and Rheumatology, Nihon University School of Medicine
-
TANAKA Toshitake
Department of Hematology and Rheumatology, Nihon University School of Medicine
-
TAKEI Kazuhiro
Department of Hematology and Rheumatology, Nihon University School of Medicine
-
Ishizuka Hikari
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Yamazaki Tetsuo
Division Of Medicine Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Takeuchi Jin
Department Of Internal Medicine Nihon University School Of Medicine
-
Takei Kazuhiro
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Tanaka Toshitake
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
TANAKA Toshitake
Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine
-
Hojo Atsuko
Division Of Medicine Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Kobayashi Sumiko
Division Of Medicine Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Yamazaki Tetsuo
Division of Cardiology, Yokohama Rosai Hospital
-
KOBAYASHI Sumiko
Division of Transfusion Service
-
NAKAGAWA Yoshiko
Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine
-
HIRABAYASHI Yukio
Department of Hematology and Rheumatology, Nihon University School of Medicine
-
Nakagawa Yoshiko
Division Of Medicine Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
UEDA Kaname
Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine
-
HOJO Atsuko
Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine
-
Ueda Kaname
Division Of Medicine Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Kobayashi Yujin
Division Of Cancer Genetics Department Of Advanced Medical Research Center Nihon University School O
-
Kobayashi Yujin
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Hirabayashi Yukio
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Iriyama Noriyoshi
Division Of Medicine Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
KISO Satomi
Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine
-
HIRABAYASHI Yukio
Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine
-
KODAIRA Hitomi
Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine
-
YAGI Mai
Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine
-
KURITA Daisuke
Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine
-
Yagi Mai
Division Of Medicine Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Kiso Satomi
Division Of Medicine Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Kodaira Hitomi
Division Of Medicine Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Kurita Daisuke
Division Of Medicine Department Of Hematology And Rheumatology Nihon University School Of Medicine
著作論文
- A case of treatment-related myelodysplastic syndrome spontaneously resolved by drug discontinuance
- A case of aggressive myeloma recognized shortly after the remission following high-dose chemotherapy with autologous peripheral blood stem cell transplantation
- An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma